Advertisement
CRL vs INMD
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRL is a Hold and INMD is a Hold.
CRL sees MACD Histogram crosses below signal line
CRL saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 04, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 49 instances where the indicator turned negative. In 39 of the 49 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 80%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day RSI Indicator for CRL moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In 22 of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at 73%.
The Momentum Indicator moved below the 0 level on November 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CRL as a result. In 63 of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 74%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 69%.
CRL broke above its upper Bollinger Band on October 26, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a +4.81% 3-day Advance, the price is estimated to grow further. Considering data from situations where CRL advanced for three days, in 199 of 284 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
The Aroon Indicator entered an Uptrend today. In 150 of 228 cases where CRL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 66%.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 3 (best 1 - 100 worst), indicating outstanding price growth. CRL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 15 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.674) is normal, around the industry mean (65.710). P/E Ratio (-70.170) is within average values for comparable stocks, (4.185). Projected Growth (PEG Ratio) (0.122) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (3.340) is also within normal values, averaging (9.775).
The Tickeron Seasonality Score of 44 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 87 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.
INMD sees its 50-day moving average cross bearishly below its 200-day moving average
The 50-day moving average for INMD moved below the 200-day moving average on November 04, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 38 of 56 cases where INMD's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 68%.
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on INMD as a result. In 77 of 101 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 76%.
The Moving Average Convergence Divergence Histogram (MACD) for INMD turned negative on November 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 34 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 79%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where INMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 73%.
The Aroon Indicator for INMD entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where INMD's RSI Oscillator exited the oversold zone, 29 of 36 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.
Following a +3.65% 3-day Advance, the price is estimated to grow further. Considering data from situations where INMD advanced for three days, in 164 of 255 cases, the price rose further within the following month. The odds of a continued upward trend are 64%.
INMD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 62 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.219) is normal, around the industry mean (4.137). P/E Ratio (10.750) is within average values for comparable stocks, (2.620). Projected Growth (PEG Ratio) (0.834) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (2.452) is also within normal values, averaging (40.124).
The Tickeron SMR rating for this company is 63 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 69 (best 1 - 100 worst), indicating slightly worse than average price growth. INMD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
CRL | INMD | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 29 | 25 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 15 Undervalued | 62 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 93 | 63 | |
PRICE GROWTH RATING 1..100 | 3 | 69 | |
P/E GROWTH RATING 1..100 | 87 | 8 | |
SEASONALITY SCORE 1..100 | 44 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CRL's Valuation (15) in the Miscellaneous Commercial Services industry is somewhat better than the same rating for INMD (62) in the null industry. This means that CRL’s stock grew somewhat faster than INMD’s over the last 12 months.
CRL's Profit vs Risk Rating (100) in the Miscellaneous Commercial Services industry is in the same range as INMD (100) in the null industry. This means that CRL’s stock grew similarly to INMD’s over the last 12 months.
INMD's SMR Rating (63) in the null industry is in the same range as CRL (93) in the Miscellaneous Commercial Services industry. This means that INMD’s stock grew similarly to CRL’s over the last 12 months.
CRL's Price Growth Rating (3) in the Miscellaneous Commercial Services industry is significantly better than the same rating for INMD (69) in the null industry. This means that CRL’s stock grew significantly faster than INMD’s over the last 12 months.
INMD's P/E Growth Rating (8) in the null industry is significantly better than the same rating for CRL (87) in the Miscellaneous Commercial Services industry. This means that INMD’s stock grew significantly faster than CRL’s over the last 12 months.
| CRL | INMD | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 73% | 2 days ago 81% |
| Stochastic ODDS (%) | 2 days ago 77% | 2 days ago 68% |
| Momentum ODDS (%) | 2 days ago 74% | 2 days ago 76% |
| MACD ODDS (%) | 2 days ago 80% | 2 days ago 79% |
| TrendWeek ODDS (%) | 2 days ago 72% | 2 days ago 66% |
| TrendMonth ODDS (%) | 2 days ago 68% | 2 days ago 70% |
| Advances ODDS (%) | 10 days ago 70% | 4 days ago 64% |
| Declines ODDS (%) | 3 days ago 69% | 2 days ago 73% |
| BollingerBands ODDS (%) | 2 days ago 68% | 2 days ago 74% |
| Aroon ODDS (%) | 2 days ago 66% | 2 days ago 68% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CRL’s FA Score shows that 2 FA rating(s) are green while INMD’s FA Score has 1 green FA rating(s).
- CRL’s FA Score: 2 green, 3 red.
- INMD’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CRL’s TA Score shows that 3 TA indicator(s) are bullish while INMD’s TA Score has 3 bullish TA indicator(s).
- CRL’s TA Score: 3 bullish, 5 bearish.
- INMD’s TA Score: 3 bullish, 6 bearish.
Price Growth
CRL (@Medical Specialties) experienced а -6.09% price change this week, while INMD (@Medical/Nursing Services) price change was +0.83% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was -6.42%. For the same industry, the average monthly price growth was -7.90%, and the average quarterly price growth was +34.49%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -3.27%. For the same industry, the average monthly price growth was -8.05%, and the average quarterly price growth was -7.48%.
Reported Earning Dates
CRL is expected to report earnings on Feb 24, 2027.
INMD is expected to report earnings on Nov 11, 2026.
Industries' Descriptions
@Medical Specialties (-6.42% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
@Medical/Nursing Services (-3.27% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
CRL and
Correlation & Price change
A.I.dvisor indicates that over the last year, CRL has been loosely correlated with RGEN. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if CRL jumps, then RGEN could also see price increases.
| Ticker / NAME | Correlation To CRL | 1D Price Change % | ||
|---|---|---|---|---|
| CRL | 100% | +7.83% | ||
| RGEN - CRL | 56% Loosely correlated | +2.97% | ||
| AZTA - CRL | 56% Loosely correlated | +4.76% | ||
| MEDP - CRL | 56% Loosely correlated | +2.86% | ||
| BRKR - CRL | 53% Loosely correlated | +5.60% | ||
| SHC - CRL | 52% Loosely correlated | +0.88% | ||
More | ||||
INMD and
Correlation & Price change
A.I.dvisor indicates that over the last year, INMD has been loosely correlated with UTMD. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if INMD jumps, then UTMD could also see price increases.
| Ticker / NAME | Correlation To INMD | 1D Price Change % | ||
|---|---|---|---|---|
| INMD | 100% | -0.52% | ||
| UTMD - INMD | 47% Loosely correlated | +1.68% | ||
| RVTY - INMD | 45% Loosely correlated | +2.84% | ||
| CRL - INMD | 45% Loosely correlated | +7.83% | ||
| MTD - INMD | 45% Loosely correlated | +2.57% | ||
| AZTA - INMD | 45% Loosely correlated | +4.76% | ||
More | ||||